Father Champions Gene Therapy Development for Rare Disease
A father invests $70 million into developing a gene therapy for his daughter’s rare condition, seeking breakthroughs for patients like her.
July 09, 2026
Entertainment
Entertainment news, movies, and celebrities
OpenEvidence Research Challenges LLM Efficacy in Health Tech
Recent research from OpenEvidence questions the effectiveness of large language models in health technology applications, presenting new insights into AI capabilities.
July 09, 2026
Psilocybin Therapy Shows Long-Lasting Benefits for Depression, Studies Indicate
Recent studies suggest that psilocybin therapy may offer enduring relief for patients with depression, presenting a significant advancement in treatment options.
July 07, 2026
Exploring the Quality of GLP-1 Telehealth Services: Key Findings from a Recent Study
A recent analysis of GLP-1 telehealth platforms reveals significant variation in service quality, highlighting the need for more regulated standards.
July 07, 2026
Vertex Pharmaceuticals Targets New Growth with $10 Billion Acquisition of Crinetics
Vertex Pharmaceuticals is set to acquire Crinetics Pharmaceuticals for $10 billion, marking a pivotal expansion into rare disease treatments.
July 07, 2026
Whistleblower Chris Deacon Exposes Insurance Fraud Amid Historic Settlement
Chris Deacon’s tireless efforts led to a $100 million settlement with Horizon Blue Cross Blue Shield, though her contributions remain overshadowed by political figures.
July 07, 2026
Rising Health Insurance Costs Push Small Businesses to the Brink
Soaring health insurance expenses are pushing small businesses to abandon employee health coverage, challenging America's employer-based system.
July 07, 2026
Medicare Proposes Significant Cuts to 340B Drug Payments for Hospitals
Medicare plans to reduce payments for 340B drugs by over 33%, a move criticized for potentially harming safety-net hospitals while benefiting for-profits.
July 02, 2026
Elevance Health Challenges Medicare Advantage Star Ratings in $115 Million Lawsuit
Elevance Health has initiated legal action against the U.S. government, claiming improper recalculation of its Medicare Advantage ratings that jeopardize $115 million in funding.
July 02, 2026
Roche's Latest KRAS Drug Sets a New Benchmark for Lung Cancer Treatment
Roche's new KRAS-targeted therapy is poised to redefine lung cancer treatment, showing impressive efficacy and safety in clinical trials.
July 02, 2026
Increased Heat Waves Intensify Health Risks for Americans
Frequent and severe heat waves are significantly impacting public health, with rising temperatures posing increased risks to Americans' wellbeing.
July 02, 2026
Biotech Sector Surges as Mid-Year Performance Hits New Highs
The biotech sector has experienced a remarkable rise in performance, with major indices celebrating significant gains as the year progresses.
July 02, 2026
Bluebird Bio's Dramatic Turnaround Under New Leadership
After a distressing buyout, Bluebird Bio's transformation into Genetix positions it to lead the market in sickle cell gene therapies by 2030.
July 02, 2026
Reviving the Presidential Fitness Test: A Step, Not a Solution for Youth Health
Experts suggest reintroducing the presidential fitness test is a positive move but insufficient alone to address childhood inactivity.
July 02, 2026
Emerging Insights: Statins and Blood Pressure Medications Mitigate Cardiovascular Risks in Obesity
A recent study highlights that older adults with obesity are achieving better cardiovascular health metrics, potentially due to increased use of statins and blood pressure drugs.
July 01, 2026
Synthetic Cells Spark Discussion on Life's Definition in New Research
A team has created potential synthetic cells, sparking debate over their life-like properties and implications for biological engineering.
July 01, 2026
Orca Bio's T-Cell Therapy Tregzi Gains FDA Approval for Blood Cancer Treatment
Orca Bio receives FDA approval for Tregzi, a personalized T-cell therapy aimed at reducing complications in blood cancer patients undergoing transplants.
July 01, 2026
Addressing Diagnostic Gaps in Ebola and Marburg Outbreak Response
Current diagnostic strategies for Ebola and Marburg viruses fail to adapt to the complexities of overlapping outbreaks, highlighting urgent needs in public health.
July 01, 2026
Key Biotech Milestones to Monitor in Q3 2026
The third quarter of 2026 promises significant biotech events, including critical trial results that could impact stock performance across the sector.
July 01, 2026
LGBTQ+ Crisis Hotline Faces Exclusion as Relaunch Approaches
The 988 LGBTQ+ crisis hotline is set to relaunch, but concerns arise over the exclusion of The Trevor Project, pivotal in its original development.
June 26, 2026